A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy

NCT02693119 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Leber's Hereditary Optic Neuropathy

Interventions

DRUG: elamipretide (MTP-131) 1% topical ophthalmic solution
DRUG: Vehicle topical ophthalmic solution

Sponsor

Stealth BioTherapeutics Inc.